| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/12/2002 | WO2002070468A2 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 09/12/2002 | WO2002070464A2 Hydrazones and their therapeutic use |
| 09/12/2002 | WO2002070462A1 Substituted amino dicarboxylic acid derivatives |
| 09/12/2002 | WO2002070461A1 Side-chain halogenated amino carboxylic acid derivatives as medicaments for treating cardiovascular diseases |
| 09/12/2002 | WO2002070460A1 Halogen-substituted amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases |
| 09/12/2002 | WO2002070459A1 Novel amino dicarboxylic acid derivatives |
| 09/12/2002 | WO2002070457A1 Inhibitor of monoamine uptake |
| 09/12/2002 | WO2002070455A1 Malic acid addition salts of terbinafine |
| 09/12/2002 | WO2002070454A1 Carbadendrimer compounds functionalised at their ends and having antimicrobial properties, methods for preparing same and compositions containing same |
| 09/12/2002 | WO2002070438A2 Compositions for delivering bisphosphonates |
| 09/12/2002 | WO2002070070A2 Compositions having improved bioavailability of eletriptan |
| 09/12/2002 | WO2002070069A2 Use of one or more shogaol(s) as an aphrodisiac |
| 09/12/2002 | WO2002070068A2 Lipoxin analogs as novel inhibitors of angiogenesis |
| 09/12/2002 | WO2002070021A1 Gastric delivery of antineoplastic agents and methods of treatment via inhibition of cancer cell using them |
| 09/12/2002 | WO2002070017A1 Siderophore antibiotic conjugates with tetra- or hexadentate iron chelators on the basis of amino acids or peptides, method for producing them and the use thereof |
| 09/12/2002 | WO2002070014A1 Compositions comprising an o/w emulsion containing conjugated linoleic acid |
| 09/12/2002 | WO2002070010A1 Graft rejection inhibitors |
| 09/12/2002 | WO2002070008A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 09/12/2002 | WO2002070007A1 Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 09/12/2002 | WO2002070000A1 Recombinant gelatin-like proteins for use as plasma expanders |
| 09/12/2002 | WO2002069994A2 Combined use of derivatives of glp-1 analogs and ppar ligands |
| 09/12/2002 | WO2002069993A1 Pharmaceutical composition made of cannabis extracts |
| 09/12/2002 | WO2002069987A2 Agent for treating diabetes mellitus |
| 09/12/2002 | WO2002069984A2 Use of hyaluronic acid uronides for the treatment of inflammatory processes |
| 09/12/2002 | WO2002069983A1 Amphotericin b aqueous composition |
| 09/12/2002 | WO2002069982A1 Medicaments |
| 09/12/2002 | WO2002069980A2 Pharmaceutically effective ginsenosides and their use |
| 09/12/2002 | WO2002069979A2 Pharmaceutical formulation comprising r-salmeterol and fluticasone propionate |
| 09/12/2002 | WO2002069978A1 Progestin co-micronized with a surfactant, pharmaceutical composition comprising same, methods for making same and uses thereof |
| 09/12/2002 | WO2002069977A1 Use of certain steroids for treatment of blood cell deficiencies |
| 09/12/2002 | WO2002069976A2 Use of ovarian hormone for increasing neural stem cell number |
| 09/12/2002 | WO2002069975A1 Use of estrogen to induce neural stem cell increase |
| 09/12/2002 | WO2002069974A1 Administration of sleep restorative agents |
| 09/12/2002 | WO2002069972A2 Triazole compounds and the use thereof in the prophylaxis and therapy of neurodegenerative diseases, cerebral trauma and cerebral ischemia |
| 09/12/2002 | WO2002069971A1 Pharmaceutical compositions and dietary supplements for treatment or improvement of arthitis |
| 09/12/2002 | WO2002069970A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 09/12/2002 | WO2002069969A1 A process for the manufacture of pharmaceutical tablets containing paroxetine hydrochloride anhydrate |
| 09/12/2002 | WO2002069968A1 New use |
| 09/12/2002 | WO2002069966A1 Injectable pharmaceutical composition for treatment and reversal of erectile dysfunction |
| 09/12/2002 | WO2002069965A1 Benzimidazole derivatives as therapeutic agents |
| 09/12/2002 | WO2002069964A1 Enteral formulation |
| 09/12/2002 | WO2002069963A2 Compositions comprising ferulic acid, caffeic acid, tannic acid or ellagic acid and their use for the preparation of a medicament for the treatment of dermatological disorders |
| 09/12/2002 | WO2002069962A1 Compositions and preparations of silymarin complex with the improved bioavailability |
| 09/12/2002 | WO2002069961A1 Il-8 receptor ligands-drugs for inflammatory and autoimmune diseases |
| 09/12/2002 | WO2002069960A2 Use of mek inhibitors for treating inflammation and virus induced hemorrhagic shock |
| 09/12/2002 | WO2002069959A1 Device for packaging an oxiplatinum solution |
| 09/12/2002 | WO2002069958A1 Thiocyanate ions for preventing and treating bse and similar animal and human diseases |
| 09/12/2002 | WO2002069957A1 Fenofibrate-containing composition |
| 09/12/2002 | WO2002069956A2 Use of carnitine for increasing testosteron |
| 09/12/2002 | WO2002069955A1 Method and formula for anti-tumor and anti-matastatic effect |
| 09/12/2002 | WO2002069954A1 Composition and methods for the treatment and prevention of bovine mastitis |
| 09/12/2002 | WO2002069953A1 Methods of treating lung inflammation |
| 09/12/2002 | WO2002069952A1 Antiinflammatory agents containing novel compounds or derivatives thereof |
| 09/12/2002 | WO2002069951A2 Composition containing a nefazonoid such as nefazodone and a serotonin-inhibitor such as fluoxetine |
| 09/12/2002 | WO2002069950A2 Tumor treatement with a combination of a substrate of mrp5 and modulators of mrp5 |
| 09/12/2002 | WO2002069949A2 Combination therapy for reduction of toxycity of chemotherapeutic agents |
| 09/12/2002 | WO2002069948A1 Use of gabaa inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators, or vitamin e for the treatment of cognitive disorders |
| 09/12/2002 | WO2002069947A2 Antisense oligonucleotides and trichostatin analogue histone deacetylase-4 inhibitors against cancer |
| 09/12/2002 | WO2002069946A2 Use of triazole compounds for prophylaxis and in therapy for neurodegenerative illnesses, brain traumas and cerebral ischaemia |
| 09/12/2002 | WO2002069945A2 Novel medicament compositions on the basis of anticholinergics and pde iv inhibitors |
| 09/12/2002 | WO2002069944A2 Novel medicament compositions based on anticholinergics and on nk1 receptor antagonists |
| 09/12/2002 | WO2002069942A1 Adhesive patch |
| 09/12/2002 | WO2002069941A1 Transdermal therapeutic system for the administration of partial dopamine-d2 agonists |
| 09/12/2002 | WO2002069940A2 Highly flexible transdermal therapeutic system having nicotine as active substance |
| 09/12/2002 | WO2002069939A2 Taste masked pharmaceutical compositions |
| 09/12/2002 | WO2002069937A1 Compounds and compositions for delivering active agents |
| 09/12/2002 | WO2002069927A1 Compositions comprising melatonin and vitamin a |
| 09/12/2002 | WO2002069926A1 Cosmetic formulations containing flavonoid derivatives |
| 09/12/2002 | WO2002069925A2 Use of $g(a)-lipoic acid in cosmetic or dermatological preparations |
| 09/12/2002 | WO2002069913A1 Skin-improving composition set |
| 09/12/2002 | WO2002069911A2 Active substance combination consisting of $g(a)-liponic acid and bioquinones |
| 09/12/2002 | WO2002069906A2 Compounds and methods for the treatment of urogenital disorders |
| 09/12/2002 | WO2002069905A2 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders |
| 09/12/2002 | WO2002069903A2 Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases |
| 09/12/2002 | WO2002069901A2 Cathepsin cysteine protease inhibitors |
| 09/12/2002 | WO2002069900A2 Methods for treating genetically-defined proliferative disorders with hsp90 inhibitors |
| 09/12/2002 | WO2002069895A2 Heterocyclic analgesic compounds and methods of use thereof |
| 09/12/2002 | WO2002069893A2 Treatment of neurological disease |
| 09/12/2002 | WO2002069892A2 METHOD FOR PROTECTING CELLS AND TISSUES FROM IONIZING RADIATION TOXICITY WITH α, β UNSATURATED ARYL SULFONES |
| 09/12/2002 | WO2002069888A2 Serotonin reuptake inhibitor formulations |
| 09/12/2002 | WO2002069887A2 Virucidal compositions |
| 09/12/2002 | WO2002069884A2 A sunburn treatment and sunburn prevention method |
| 09/12/2002 | WO2002069883A2 Cathecin derivatives as leukocyte elastase inhibitors for treating inflammatory disorders |
| 09/12/2002 | WO2002069799A1 Method of predicting stroke evolution utilising mri |
| 09/12/2002 | WO2002069740A1 Compositions containing creatine and creatinine |
| 09/12/2002 | WO2002057409A3 Antisense modulation of src-2 expression |
| 09/12/2002 | WO2002053099A3 Methods and compositions for treating periodontal disease |
| 09/12/2002 | WO2002050030A3 Cycloalkylfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases |
| 09/12/2002 | WO2002050001A3 Non-halogenated naphthol compounds and antimicrobial compositions containing the same |
| 09/12/2002 | WO2002049576A3 Fab i and inhibition of apicomplexan parasites |
| 09/12/2002 | WO2002048122A3 Benzamidine derivatives |
| 09/12/2002 | WO2002047703A3 Immune system stimulation |
| 09/12/2002 | WO2002044187A3 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
| 09/12/2002 | WO2002044113A3 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 09/12/2002 | WO2002043742A8 Cyclodextrins and reversal of atherosclerosis |
| 09/12/2002 | WO2002043720A3 Compositions comprising temozolomide and thalidomide and methods for the treatment of cancer |
| 09/12/2002 | WO2002028862A3 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| 09/12/2002 | WO2002028859A3 Condensed pyridoindole derivatives |
| 09/12/2002 | WO2002026717A3 Hydroxy acid integrin antagonists |
| 09/12/2002 | WO2002022132A3 Novel topical oestroprogestational compositions with systemic effect |